Cardiovascular And Soft Tissue Repair Patches Market Size, Share & Trend Analysis Report By Application (Cardiac Repair, Vascular Repair, Pericardial Repair, Dural Repair, Soft Tissue Repair), By Raw Material, By Region, And Segment Forecasts, 2022 - 2030

Cardiovascular And Soft Tissue Repair Patches Market Growth & Trends

The global cardiovascular and soft tissue repair patches market size is expected to reach USD 7.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. The rapidly rising prevalence of congenital heart diseases, such as Atrial Septal Defect (ASD)and the ventricular septal defect is expected to drive the demand for the patches. In addition, increasing implementation of patches in medical procedures and growing sports injuries is expected to support the development and growth of the market over the forthcoming years. As per studies, ASD is the second most common type of congenital heart disease and the incidence rate across the global population is recorded to be 56 per 100,000 live births.

One of the key driving market forces is the rapidly rising prevalence of cardiovascular diseases. Changing lifestyles, growing obesity levels, adoption of unhealthy lifestyle habits, increasing alcohol consumption and smoking, and growing geriatric population are driving the incidence of cardiac disorders. As per World Health Organization estimates, cardiovascular diseases account for the largest share of 32% or 17.9 million deaths annually. As per the Centers for Disease Control and Prevention estimates, approximately 695,000 deaths in the U.S. are due to underlying cardiac diseases. Coronary heart diseases are recorded in the majority of cardiac disorder-related deaths. As per the Centers for Disease Control and Prevention estimates, coronary heart diseases accounted for 360,900 deaths in the U.S. in 2019.

Another key driving force supporting growth is the rising prevalence of hernias such as inguinal hernia, umbilical hernia, congenital diaphragmatic hernia, ventral hernia, and others. Some of the risk factors associated with hernias are heavy weight lifting, abdominal surgery, ascites, constipation, and chronic cough which increases the pressure on intra-abdominal regions resulting in abdominal hernias. Inguinal hernias are the commonest abdominal hernias and the incidence rate of inguinal hernia repairs in the U.K. is 10 per 100,000 individuals and in the U.S. are 28 per 100,000 individuals. Congenital diaphragmatic hernia is caused due to genetic factors and residual embryological channel defects. The abovementioned factors are driving the demand for patches in therapeutic procedures and wound care management.

Cardiovascular And Soft Tissue Repair Patches Market Report Highlights

  • The soft tissue repair segment dominated the market in 2021 due to the rapidly growing incidence rate of hernias across the globe
  • The ePTFE segment dominated the market in 2021 owing to the multiple benefits associated with ePTFE, such as high durability, easy availability, and high tensile strength
  • North America dominated the market in 2021 owing to the growing disease burden, advancing healthcare infrastructure, rising disposable income, and growing trend of minimally invasive surgeries
Profiled Companies

Baxter
Admedus
Abbott (St Jude Medical)
LeMaitre Vascular Inc.
Edwards Life Sciences Corporation
Glycar SA Pty Ltd.
LabCor
Cryolife, Inc.
CorMatrix
Terumo Medical Corporation
Bard Peripheral Vascular Inc.
Neovasc
W.L. Gore & Associates, Inc.
B.Braun
Novomedics
TEI Biosciences Inc.
Perouse Medical
Gunze Limited
Atriummed
Maverick Bioscience
Southern Lights Biomaterials

Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Research Methodology
1.1 Market Segmentation &Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Cardiovascular and Soft Tissue Repair Patches Market Variables, Trends & Scope
3.1 Cardiovascular and soft tissue repair patches Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 User Perspective Analysis
3.4.1 Consumer behaviour analysis
3.4.2 Market influencer analysis
3.5 Procedure Cost Analysis/Breakdown
3.6 List of Key End-users
3.7 Technology Overview
3.7.1 Technology timeline
3.8 Regulatory Framework
3.8.1 Reimbursement framework
3.8.2 Standards and compliances
3.9 Cardiovascular and soft tissue repair patches Market Dynamics
3.9.1 Market driver analysis
3.9.2 Market restraint analysis
3.9.3 Industry challenges
3.10 Cardiovascular and Soft Tissue Repair Patches Market Analysis Tools
3.10.1 Industry analysis - Porter’s
3.10.1.1 Supplier power
3.10.1.2 Buyer power
3.10.1.3 Substitution threat
3.10.1.4 Threats from new entrant
3.10.1.5 Competitive rivalry
3.10.2 PESTEL analysis
3.10.2.1 Political landscape
3.10.2.2 Enviornmental landscape
3.10.2.3 Social landscape
3.10.2.4 Technology landscape
3.10.2.5 Economic landscape
3.10.2.6 Legal landscape
3.10.3 Major deals & strategic alliances analysis
3.10.3.1 Joint Ventures
3.10.3.2 Mergers & Acquisitions
3.10.3.3 Licensing & Partnership
3.10.4 Market entry strategies
Chapter 4 Cardiovascular and Soft Tissue Repair Patches Market- Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Companyranking, by region
4.5 Private Companies
4.5.1 List of key emerging companies /technology disruptors/innovators
4.5.2 Regional network map
4.5.3 Company market position analysis
Chapter 5 Cardiovascular and soft Tissue Repair Patches Market: ApplicationEstimates & Trend Analysis
5.1 Definition & Scope
5.2 Application Market Share Analysis, 2021&2030
5.3 Segment Dashboard
5.4 Global Cardiovascular and soft Tissue Repair Patches Market Revenue Estimates and Forecasts, by Application, 2014 - 2030 (USD Million)
5.4.1 Cardiac repair
5.4.1.1 Market revenue estimates and forecasts for cardiac repair, 2016 - 2030 (USD Million)
5.4.1.2 Atrial septal defect
5.4.1.2.1 Market revenue estimates and forecasts for atrial septal defect, 2016 - 2030 (USD Million)
5.4.1.3 Common atrium
5.4.1.3.1 Market revenue estimates and forecasts for common atrium, 2016 - 2030 (USD Million)
5.4.1.4 Defects of the endocardial cushion
5.4.1.4.1 Market revenue estimates and forecasts for defects of the endocardial cushion, 2016 - 2030 (USD Million)
5.4.1.5 Ventricular septal defect
5.4.1.5.1 Market revenue estimates and forecasts for ventricular septal defect, 2016 - 2030 (USD Million)
5.4.1.6 Tetralogy of Fallot
5.4.1.6.1 Market revenue estimates and forecaststetralogy of Fallot, 2016 - 2030 (USD Million)
5.4.1.7 Right Ventricular Outflow Tract Reconstruction
5.4.1.7.1 Market revenue estimates and forecasts for right ventricular outflow tract reconstruction, 2016 - 2030 (USD Million)
5.4.1.8 Suturebleeding
5.4.1.8.1 Market revenue estimates and forecasts for suture bleeding, 2016 - 2030 (USD Million)
5.4.1.9 Market revenue estimates and forecasts for cardiac repair, by raw materials, 2016 - 2030 (USD Million)
5.4.2 Vascular repair and reconstruction
5.4.2.1 Market revenue estimates and forecasts for vascular repair and reconstruction, 2016 - 2030 (USD Million)
5.4.2.2 Carotid endarterectomy
5.4.2.2.1 Market revenue estimates and forecasts for carotid endarterectomy, 2016 - 2030 (USD Million)
5.4.2.3. Anomalous connection of the pulmonary veins
5.4.2.3.1 Market revenue estimates and forecasts for anomalous connection of the pulmonary veins, 2016 - 2030 (USD Million)
5.4.2.4 Transposition of the great vessels
5.4.2.4.1 Market revenue estimates and forecasts for transposition of the great vessels, 2016 - 2030 (USD Million)
5.4.2.5 Reconstruction of portal and superior mesenteric veins
5.4.2.5.1 Market revenue estimates and forecasts for reconstruction of portal and superior mesenteric veins, 2016 - 2030 (USD Million)
5.4.2.6 Other vascular repair and reconstruction
5.4.2.6.1 Market revenue estimates and forecasts for other vascular repair and reconstruction, 2016 - 2030 (USD Million)
5.4.2.7 Market revenue estimates and forecasts for vascular repair and reconstruction, by raw materials, 2016 - 2030 (USD Million)
5.4.3 Pericardial repair
5.4.3.1 Market revenue estimates and forecasts for pericardial repair, 2016 - 2030 (USD Million)
5.4.3.2 Market revenue estimates and forecastspericardial repair, by raw materials, 2016 - 2030 (USD Million)
5.4.4 Dural repair
5.4.4.1 Dural repair market revenue estimates and forecasts, 2016 - 2030 (USD Million)
5.4.4.2 Market revenue estimates and forecasts for dural repair, by raw materials, 2016 - 2030 (USD Million)
5.4.5 Soft tissue repair
5.4.5.1 Soft tissue repair market revenue estimates and forecasts, 2016 - 2030 (USD Million)
5.4.5.2 Defects of abdominal wall
5.4.5.2.1 Market revenue estimates and forecasts for defects of abdominal wall, 2016 - 2030 (USD Million)
5.4.5.3 Defects of thoracic wall
5.4.5.3.1 Market revenue estimates and forecasts for defects of abdominal wall, 2016 - 2030 (USD Million)
5.4.5.4 Gastric binding
5.4.5.4.1 Market revenue estimates and forecasts for gastric binding, 2016 - 2030 (USD Million)
5.4.5.5 Hernias
5.4.5.5.1 Market revenue estimates and forecasts for Hernias, 2016 - 2030 (USD Million)
5.4.5.6 Market revenue estimates and forecasts for soft tissue repair, by raw materials, 2016 - 2030 (USD Million)
Chapter 6 Cardiovascular and Soft Tissue Repair Patches Market: Raw Materials Estimates & Trend Analysis
6.1 Definition & Scope
6.2 Raw Materials Market Share Analysis, 2021&2030
6.3 Segment Dashboard
6.4 Global Cardiovascular and soft Tissue Repair Patches Market Revenue Estimates and Forecasts, by Raw Materials, 2016 - 2030 ( USD Million)
6.4.1 ePTFE
6.4.1.1 ePTFE based patches market revenue estimates and forecasts, 2016 - 2030 (USD Million)
6.4.2 Biomaterial and tissue engineered materials
6.4.2.1 Biomaterial and tissue engineered material based patches market revenue estimates and forecasts, 2016 - 2030 (USD Million)
6.4.3 Other raw materials
6.4.3.1 Otherrawmaterial-based patches market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 7 Cardiovascular and soft tissue repair patches Market: Regional Estimates & Trend Analysis, By Application and By Raw Materials
7.1 Regional Cardiovascular and Soft Tissue Repair Patches Market Snapshot (Market size, CAGR, top verticals, top trends)
7.2 List of Key Players, by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 MEA
7.3 North America
7.3.1 North America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.3.2 North America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.3.3.U.S.
7.3.3.1 U.S. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.3.3.2 U.S. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.3.4 Canada
7.3.4.1 Canada cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.3.4.2 Canada cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.4 Europe
7.4.1 Europe cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.4.2 Europe cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.4.3. U.K.
7.4.3.1 U.K. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.4.3.2 U.K. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.4.4 Germany
7.4.4.1 Germany cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.4.4.2 Germany cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.4.5. France
7.4.5.1 France cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.4.5.2 France cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.4.6 Spain
7.4.6.1 Spain cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.4.6.2 Spain cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.4.7.Italy
7.4.7.1 Italy cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.4.7.2 Italy cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.4.8 Russia
7.4.8.1 Russia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.4.8.2 Russia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.5.2 Asia Pacific cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.5.3. Japan
7.5.3.1 Japan cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.5.3.2 Japan cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.5.4 China
7.5.4.1 China cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.5.4.2 China cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.5.5. India
7.5.5.1 India cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.5.5.2 India cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.5.6 Australia
7.5.6.1 Australia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.5.6.2 Australia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.5.7. Singapore
7.5.7.1 Singapore cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.5.7.2 Singapore cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.5.8 South Korea
7.5.8.1 South Korea cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.5.8.2 South Korea cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.6 Latin America
7.6.1 Latin America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.6.2 Latin America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.6.3. Brazil
7.6.3.1 Brazil cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.6.3.2 Brazil cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.6.4 Mexico
7.6.4.1 Mexico cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.6.4.2 Mexico cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.6.5. Argentina
7.6.5.1 Argentina cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.6.5.2 Argentina cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.7 MEA
7.7.1 MEA cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.7.2 MEA cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.7.3. South Africa
7.7.3.1 South Africa cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.7.3.2 South Africa cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.7.4 Saudi Arabia
7.7.4.1 Saudi Arabia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.7.4.2 Saudi Arabia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.7.5. UAE
7.7.5.1 UAE cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
7.7.5.2 UAE cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2016 - 2030 (USD Million)
7.8 SWOT Analysis, by Factor
7.8.1 North America
7.8.2 Europe
7.8.3 Asia Pacific
7.8.4 Latin America
7.8.5 Middle East & Africa
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Baxter
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Admedus
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Abbott (St Jude Medical)
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Productbenchmarking
8.1.3.4 Strategic initiatives
8.1.4 LeMaitre Vascular Inc.
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Edwards Life Sciences Corporation
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Productbenchmarking
8.1.5.4 Strategic initiatives
8.1.6 Glycar SA Pty Ltd.
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Productbenchmarking
8.1.6.4 Strategic initiatives
8.1.7 LabCor
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Cryolife, Inc.
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 CorMatrix
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Terumo Medical Corporation
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
8.1.11 Bard Peripheral Vascular Inc.
8.1.11.1 Company overview
8.1.11.2 Financial performance
8.1.11.3 Product benchmarking
8.1.11.4 Strategic initiatives
8.1.12 Neovasc
8.1.12.1 Company overview
8.1.12.2 Financial performance
8.1.12.3 Product benchmarking
8.1.12.4 Strategic initiatives
8.1.13 W.L. Gore & Associates, Inc.
8.1.13.1 Company overview
8.1.13.2 Financial performance
8.1.13.3 Product benchmarking
8.1.13.4 Strategic initiatives
8.1.14 B.Braun
8.1.14.1 Company overview
8.1.14.2 Financial performance
8.1.14.3 Product benchmarking
8.1.14.4 Strategic initiatives
8.1.15 Novomedics
8.1.15.1 Company overview
8.1.15.2 Financial performance
8.1.15.3 Product benchmarking
8.1.15.4 Strategic initiatives
8.1.16 TEI Biosciences Inc.
8.1.16.1 Company overview
8.1.16.2 Financial performance
8.1.16.3 Product benchmarking
8.1.16.4 Strategic initiatives
8.1.17 Perouse Medical
8.1.17.1 Company overview
8.1.17.2 Financial performance
8.1.17.3 Product benchmarking
8.1.17.4 Strategic initiatives
8.1.18 Gunze Limited
8.1.18.1 Company overview
8.1.18.2 Financial performance
8.1.18.3 Product benchmarking
8.1.18.4 Strategic initiatives
8.1.19 Atriummed
8.1.19.1 Company overview
8.1.19.2 Financial performance
8.1.19.3 Product benchmarking
8.1.19.4 Strategic initiatives
8.1.20 Maverick Bioscience
8.1.20.1 Company overview
8.1.20.2 Financial performance
8.1.20.3 Product benchmarking
8.1.20.4 Strategic initiatives
8.1.21 Southern Lights Biomaterials
8.1.21.1 Company overview
8.1.21.2 Financial performance
8.1.21.3 Product benchmarking
8.1.21.4 Strategic initiatives
8.2 List of Other Companies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings